Astellas Pharma US, Inc. - Strategic SWOT Analysis Review

Astellas Pharma US, Inc. (Astellas US) is a US based pharmaceutical company, based in the US. The company is engaged in the development and manufacture of pharmaceutical products. Moreover, the company is involved in research and development activities. Furthermore, the company's key therapeutic areas of interest include central nervous system, diabetes, metabolic disease, kidney disease, infectious disease, immunology, inflammation, oncology, pain, transplantation, and urology. Additionally, the company's other therapeutic areas of interest include dermatology, gastrointestinal disease and acute care cardiovascular disease. The company focuses on alliances to expand its business. . It has entered into collaboration with several companies including Boehringer Ingelheim, Cardiome Pharma Corporation, Gilead Palo Alto, Inc., GlaxoSmithKline and Medivation, Inc. June, 2011, the company announced result of URTAC the first Phase III study with Tarceva ion Western patients with a genetically distinct type of advanced non%li%small cell lung cancer (NSCLC). It operates as a subsidiary of Astellas Pharma Inc., Japan and was formed by the merger of Yamanouchi and Fujisawa. Astellas US acquired Agensys, Inc., one of the leading biotech in therapeutic antibody research and development in cancer. Astellas US is headquartered at Deerfield in Illinois, the US.
Astellas Pharma US, Inc. Key Recent Developments

May 19, 2011: Astellas Appoints Mark Reisenauer As Vice President Of Sales And Marketing for US Oncology Franchise

This comprehensive SWOT profile of Astellas Pharma US, Inc. provides you with an in-depth strategic analysis of the company's businesses and operations. The profile will give you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the 'Profile on Demand' Service, covering over 50,000 of the world's leading companies. Once purchased, We will comprehensively research and author a full strategic analysis of Astellas Pharma US, Inc. and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

• Business description - A detailed description of the company's operations and business divisions.
• Corporate strategy - Analyst's summarization of the company's business strategy.
• SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
• Company history - Progression of key events associated with the company.
• Major products and services - A list of major products, services and brands of the company.
• Key competitors - A list of key competitors to the company.
• Key employees - A list of the key executives of the company.
• Executive biographies - A brief summary of the executives' employment history.
• Key operational heads - A list of personnel heading key departments/functions.
• Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities - A list of key manufacturing facilities of the company.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Contents

SECTION 1 - ABOUT THE COMPANY

Astellas Pharma US, Inc. - Key Information
Astellas Pharma US, Inc. - Overview
Astellas Pharma US, Inc. - Key Employees
Astellas Pharma US, Inc. - Key Employee Biographies
Astellas Pharma US, Inc. - Key Operational Heads
Astellas Pharma US, Inc. - Major Products and Services
Astellas Pharma US, Inc. - History
Astellas Pharma US, Inc. - Company Statement
Astellas Pharma US, Inc. - Locations And Subsidiaries
Astellas Pharma US, Inc. - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

SECTION 2 - COMPANY ANALYSIS

Astellas Pharma US, Inc. - Business Description
Astellas Pharma US, Inc. - Corporate Strategy
Astellas Pharma US, Inc. - SWOT Analysis
SWOT Analysis - Overview
Astellas Pharma US, Inc. - Strengths
Astellas Pharma US, Inc. - Weaknesses
Astellas Pharma US, Inc. - Opportunities
Astellas Pharma US, Inc. - Threats
Astellas Pharma US, Inc. - Key Competitors

SECTION 3 - APPENDIX

Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Astellas Pharma US, Inc., Key Information
Astellas Pharma US, Inc., Major Products and Services
Astellas Pharma US, Inc., History
Astellas Pharma US, Inc., Key Employees
Astellas Pharma US, Inc., Key Employee Biographies
Astellas Pharma US, Inc., Key Operational Heads
Astellas Pharma US, Inc., Other Locations
Astellas Pharma US, Inc., Subsidiaries
Astellas Pharma US, Inc., Key Manufacturing facilities
Astellas Pharma US, Inc., Key Competitors
Astellas Pharma US, Inc., SWOT Analysis
Currency Codes Skip to top